Skip to main content
DNA Labs India

FGF12 Gene Early infantile epileptic encephalopathy type 47 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

FGF12 Gene Early infantile epileptic encephalopathy type 47 NGS Genetic Test

Short Name: FGF12 EIEE47 NGS Test

Also known as: EIEE47 Genetic Test, FGF12 Gene Mutation Test, FGF12 Sequencing Test

FGF12 Gene Early infantile epileptic encephalopathy type 47 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results typically arrive in 3 to 4 weeks from the date the sample is received at the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestInfants🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this NGS genetic test is to detect pathogenic mutations in the FGF12 gene that cause Early Infantile Epileptic Encephalopathy Type 47 (EIEE47). Confirming a genetic basis for early-onset seizures helps guide clinical management, prognostication, and family genetic counseling.

Test Code
4038
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results typically arrive in 3 to 4 weeks from the date the sample is received at the laboratory.
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

A clinical history of the patient and a genetic counselling session to draw a pedigree chart of affected family members is required. No special preparation such as fasting is needed.

Method: Peripheral blood collection, FTA card blood spot, or extracted DNA submission

Step 2

Laboratory Analysis

A blood sample will be collected by venipuncture. Alternatively, a few drops of blood may be placed on an FTA card, or an extracted DNA sample may be provided.

Step 3

Report Delivery

No restrictions. The turnaround time is typically 3 to 4 weeks. Reports will be shared and a genetic counselor will explain the results.

Timeline: Results typically arrive in 3 to 4 weeks from the date the sample is received at the laboratory.

Patient Instructions

1
Before the Test:A clinical history and genetic counseling session are required to draw a pedigree. No special preparation such as fasting is needed.
2
During the Test:A blood sample is collected by venipuncture or a few drops are placed on an FTA card. Alternative to submit an extracted DNA sample.
3
After the Test:No restrictions. Results are typically available in 3 to 4 weeks. A genetic counselor will help interpret the report.

About This Test

Who Should Get This Test

The purpose of this NGS genetic test is to detect pathogenic mutations in the FGF12 gene that cause Early Infantile Epileptic Encephalopathy Type 47 (EIEE47). Confirming a genetic basis for early-onset seizures helps guide clinical management, prognostication, and family genetic counseling.

How to Prepare

  • Provide clinical history and prior investigation records.
  • Genetic counseling session to construct a three-generation pedigree.
  • No fasting is required.
  • Inform about any ongoing medications or recent transfusions.
  • Samples can be collected at home or at a designated collection center.

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"Genetic testing for EIEE47 should be considered in infants presenting with early-onset epilepsy and developmental delay. A confirmed molecular diagnosis enables family counseling and informs recurrence risk."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Collection MethodPeripheral blood collection, FTA card blood spot, or extracted DNA submission

Sample Stability

Blood (EDTA)
FTA Card Blood Spot
Extracted DNA
Sample Rejection Criteria:
  • Clotted or hemolyzed blood sample
  • Improperly labelled sample
  • Insufficient DNA quantity for NGS
  • Incomplete clinical history or pedigree information

Understanding Your Results

The FGF12 gene test is interpreted as positive for a pathogenic mutation or negative for pathogenic mutations. A positive result confirms the molecular diagnosis of EIEE47, while a negative result reduces the likelihood but does not completely exclude the disorder.
Positive - A pathogenic or likely pathogenic variant identified in the FGF12 gene confirms the diagnosis of EIEE47.
Negative - No pathogenic variants identified; clinical suspicion should be re-evaluated.
Variant of Uncertain Significance (VUS) - Further testing or family segregation studies may be required.
⚠️ When to Consult a Doctor:

If your infant has early-onset seizures, developmental delay, or suspected EIEE47, consult a pediatric neurologist or clinical geneticist immediately. Discuss genetic testing and counseling for early intervention.

Limitations

  • This NGS-based single-gene test may not detect large exonic deletions/duplications, deep intronic variants, or structural rearrangements.
  • A negative result does not entirely rule out EIEE47 if clinical suspicion is high; additional testing such as a gene panel or whole exome sequencing may be considered.

Risks & Considerations

  • Pain or bruising at the blood draw site
  • Vasovagal reaction (rare)
  • Infection (very rare)

Interfering Factors

  • No specific interfering substances are documented for this genetic test. Results should be interpreted in the context of clinical symptoms and family history.

Frequently Asked Questions

What is the FGF12 gene?
The FGF12 gene provides instructions for making fibroblast growth factor 12, a protein important for regulating neuronal activity. Mutations in this gene are associated with early infantile epileptic encephalopathy type 47.
What is Early Infantile Epileptic Encephalopathy Type 47 (EIEE47)?
EIEE47 is a rare genetic neurological disorder characterized by recurrent seizures starting in early infancy, along with developmental delay, intellectual disability, abnormal muscle tone, and other neurological issues.
How is EIEE47 inherited?
The inheritance pattern of EIEE47 should be clarified by a clinical geneticist. Many EIEE genes are autosomal dominant with de novo mutations. Genetic counseling can provide accurate recurrence risks for your family.
What are the symptoms of EIEE47?
Symptoms include focal or tonic-clonic seizures before three months of age, frequent seizures, developmental delay, intellectual disability, abnormal muscle tone, feeding difficulty, and microcephaly.
How is EIEE47 diagnosed?
EIEE47 is confirmed through genetic testing. The FGF12 NGS genetic test analyzes DNA from a blood or FTA card sample to identify mutations in the FGF12 gene.
What is the cost of the FGF12 gene NGS test at DNA Labs India?
The test costs INR 20,000. This includes the genetic test and a consultation with a genetic counselor to discuss the results.
What sample is required for the test?
The test can be performed on a blood sample, extracted DNA, or one drop of blood placed on an FTA card.
Is fasting required before the test?
No, fasting is not required. However, you should provide the patient's clinical history and attend a genetic counseling session to draw a family pedigree.
How long does it take to get the reports?
Reports are typically available in 3 to 4 weeks after the sample reaches the laboratory.
What does a positive test result mean?
A positive result means a pathogenic or likely pathogenic variant was identified in the FGF12 gene, confirming the molecular diagnosis of EIEE47.
Does the test include genetic counseling?
Yes, the price includes a genetic counselor consultation to review the clinical history, obtain a pedigree, and explain the results and implications.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for this test across multiple cities in India. Please check the website for availability.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.